You are about to leave
this Takeda website
Takeda has no control over the content or presentation of the third-party site you are about to view.
Rest assured that patients like yourself continue to be our top priority.
At Takeda, we are currently experiencing low inventory of Vyvanse capsules due to a manufacturing delay compounded by increased demand. Recognizing that this delay could impact your ability to fill your prescription for Vyvanse, we have mobilized appropriate resources to replenish our supply as quickly as possible.
This has temporarily impacted our ability to provide adequate supply to pharmaceutical distribution wholesalers who, in turn, supply retail pharmacies, like Walgreens, CVS, Rite Aid, etc. We anticipate that this delay will affect the 40mg, 60mg, and 70mg dosage strengths. Supply of the 40mg strength will dip in mid-June and will be replenished in a few weeks. The impact to the 60mg and 70mg strengths is expected to begin in late June or early July and continue into September. It is possible that an increased demand on other dosage strengths of Vyvanse may occur, resulting in localized shortages of these other strengths. If this supply situation affects you, please work with your healthcare provider to consider other therapeutic options for your treatment and care.
We regret this inconvenience and potential disruption in your treatment. If you are unable to fill your prescription for Vyvanse at your current retail pharmacy, we encourage you to contact your healthcare provider to discuss potential alternatives during this disruption.
If your healthcare provider determines that the best therapeutic approach for you is to prescribe other strengths of Vyvanse to reach your daily dosage, Takeda will cover some Vyvanse prescription co-pay costs, so the majority of patients do not experience increased prescription co-payment amounts for Vyvanse during this supply shortage.* Please note that you must be a participant in the savings card program, and that all other terms and eligibility requirements for the Vyvanse savings card program continue to apply. Information on this program can be found .
If you have additional questions or concerns about this issue, please call 1-877–TAKEDA-7 (1-877-825-3327).
*Each patient’s insurance coverage may be different and can impact the patient’s co-pay when filling their prescription for Vyvanse. Some patients may experience an increase in their co-pay amount when filling their Vyvanse prescription with a combination of dosage strengths.